インピンジメント症候群市場- 世界の産業規模、シェア、動向、機会、予測、筋骨格系疾患の種類別、診断・画像診断技術別、治療法別、エンドユーザー別、地域別、競合別、2020～2030年

インピンジメント症候群の世界市場は、2024年に81億2,000万米ドルと評価され、予測期間中のCAGRは7.43%で、2030年には125億1,000万米ドルに達すると予測されています。

インピンジメント症候群は、肩のインピンジメントとしても知られ、世界中で数百万人が罹患している一般的な筋骨格系の疾患です。肩の腱が圧迫されたり刺激されたりすることで発症し、痛み、可動域の減少、機能的制限を引き起こします。この疾患の診断、治療、治療を含む世界のインピンジメント症候群市場は、近年著しい成長を遂げています。インピンジメント症候群市場には、X線、MRIスキャン、身体検査などの診断ツールや、理学療法、コルチコステロイド注射、低侵襲手術などの非外科的・外科的治療など、さまざまな製品とサービスが含まれます。この市場の成長を促進する主な要因としては、インピンジメント症候群の罹患率の上昇、筋骨格系障害に対する意識の高まり、医療技術の進歩などが挙げられます。インピンジメント症候群の有病率は世界的に上昇傾向にあり、その主な原因は人口の高齢化と不良姿勢や座りがちな行動などのライフスタイル要因です。肩の痛みや不快感で診察を受ける人が増えるにつれ、診断や治療の選択肢に対する需要が高まっています。インピンジメント症候群の治療では、低侵襲の手術技術が人気を博しています。関節鏡のような手技は、従来の開腹手術に比べて回復が早く、術後の痛みも軽減されるため、これらの手技に対する需要が高まっています。多血小板血漿（PRP）や幹細胞治療などの再生療法は、インピンジメント症候群の潜在的治療法として台頭してきています。これらの治療は、身体の自然治癒プロセスを刺激することを目的としており、侵襲が少なく、より効果的な治療法を提供する可能性があります。COVID-19の大流行は、ヘルスケアにおける遠隔医療と遠隔モニタリングの採用を加速させました。これらの技術により、患者はインピンジメント症候群の診察やフォローアップケアにアクセスしやすくなり、便利で効率的なヘルスケアソリューションを提供できるようになりました。インピンジメント症候群の世界市場は、認知度の向上、医療技術の進歩、病態の有病率の上昇に牽引され、成長に向かっています。償還の問題や競合といった課題が存在する一方で、個別化医療、新興市場、共同研究、デジタルヘルスソリューションといったビジネスチャンスは、市場に有望な未来をもたらします。研究と技術革新が進むにつれ、インピンジメント症候群市場は世界中の患者により良い治療と結果を提供できる可能性を秘めています。

市場促進要因

インピンジメント症候群の有病率の増加によるインピンジメント症候群の世界市場の拡大

主な市場課題

限られた認知度と誤診

主な市場動向

技術の進歩

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界のインピンジメント症候群市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 筋骨格系疾患の種類別（変形性関節症、関節リウマチ、骨粗鬆症、背中と首の痛み、肩インピンジメント症候群、膝の痛みと障害、股関節の痛みと障害、外傷と骨折、スポーツ傷害、その他）
  • 診断・画像診断技術別（X線、磁気共鳴画像（MRI）、コンピューター断層撮影（CT）スキャン、超音波、関節鏡検査、その他）
  • 治療法別（薬物療法と外科的介入）
  • エンドユーザー別（病院・診療所、外来診療センター、その他）
  • 地域別
  • 企業別（2024年）
• 市場マップ

第6章 北米のインピンジメント症候群市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州のインピンジメント症候群市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン

第8章 アジア太平洋地域のインピンジメント症候群市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米のインピンジメント症候群市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカのインピンジメント症候群市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収（ある場合）
• 製品の発売（ある場合）
• 最近の動向

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Bioventus LLC
• Orthofix Medical Inc.
• Breg, Inc.
• ConMed Corporation
• Ossur hf.
• Arthrex, Inc.
• Globus Medical, Inc.
• NuVasive, Inc.
• Stryker Corporation
• Medtronic plc

第15章 戦略的提言

Global Impingement Syndrome Market was valued at USD 8.12 Billion in 2024 and is expected to reach USD 12.51 Billion by 2030 with a CAGR of 7.43% during the forecast period. Impingement syndrome, also known as shoulder impingement, is a common musculoskeletal condition that affects millions of people worldwide. It occurs when the tendons in the shoulder become compressed or irritated, leading to pain, reduced range of motion, and functional limitations. The global impingement syndrome market, which includes diagnostics, treatments, and therapies for this condition, has witnessed significant growth in recent years. The impingement syndrome market comprises a range of products and services, including diagnostic tools such as X-rays, MRI scans, and physical examinations, as well as non-surgical and surgical treatments like physical therapy, corticosteroid injections, and minimally invasive procedures. Key factors driving the growth of this market include the rising incidence of impingement syndrome, increasing awareness about musculoskeletal disorders, and advancements in medical technology. The prevalence of impingement syndrome is on the rise globally, primarily due to aging populations and lifestyle factors such as poor posture and sedentary behavior. As more individuals seek medical attention for shoulder pain and discomfort, the demand for diagnosis and treatment options is growing. Minimally invasive surgical techniques have gained popularity in the treatment of impingement syndrome. Procedures like arthroscopy offer quicker recovery times and reduced post-operative pain compared to traditional open surgery, driving demand for these techniques. Regenerative therapies such as platelet-rich plasma (PRP) and stem cell therapy are emerging as potential treatments for impingement syndrome. These therapies aim to stimulate the body's natural healing processes, offering a less invasive and potentially more effective treatment option. The COVID-19 pandemic accelerated the adoption of telemedicine and remote monitoring in healthcare. These technologies have made it easier for patients to access consultations and follow-up care for impingement syndrome, providing a convenient and efficient healthcare solution. The global impingement syndrome market is poised for growth, driven by increasing awareness, advancements in medical technology, and a rising prevalence of the condition. While challenges such as reimbursement issues and competition exist, opportunities in personalized medicine, emerging markets, collaborative research, and digital health solutions offer a promising future for the market. As research and innovation continue to advance, the impingement syndrome market has the potential to provide better care and outcomes for patients worldwide.

Key Market Drivers

Rising Prevalence of Impingement Syndrome is Driving the Global Impingement Syndrome Market

Impingement syndrome, also known as shoulder impingement, is a common orthopedic condition that affects millions of people worldwide. This condition occurs when the tendons or bursa in the shoulder become compressed or irritated, leading to pain, limited range of motion, and decreased quality of life. In recent years, the global Impingement Syndrome market has witnessed significant growth due to the rising prevalence of this condition and the increasing demand for effective treatment options.

Impingement syndrome primarily affects the shoulder joint, making it a common orthopedic ailment. It is often seen in individuals who engage in repetitive overhead activities, such as athletes, manual laborers, and individuals who perform tasks that require constant shoulder use. The aging population also plays a significant role in the increasing prevalence of this condition, as degenerative changes in the shoulder joint can make individuals more susceptible to impingement. Moreover, lifestyle factors such as poor posture, sedentary habits, and obesity contribute to the development of Impingement Syndrome. As these risk factors become more prevalent in modern society, the number of people diagnosed with shoulder impingement continues to rise. According to a study, "Shoulder impingement syndrome: impingement view and arthrography study based on 100 cases", aprospective evaluation was conducted to assess the combination of shoulder impingement views and arthrography in patients with chronic shoulder pain. A total of 523 patients with chronic shoulder pain underwent X-rays using both conventional and impingement views. Among them, 100 patients (mean age 62) were found to have subacromial bony spurs on the impingement view and underwent arthrography. These patients were divided into two groups based on the degree of spur formation, specifically whether the spur size exceeded half the acromial width, measured from the outer margin to the acromioclavicular joint. Of the 100 subacromial spurs identified on the impingement view, only 18 were visible on the conventional view, as assessed by an independent radiologist. Arthrography revealed 35 cases of rotator cuff tears, and the size of the bony spur was significantly associated with the occurrence of rotator cuff tears (P < 0.02).

Key Market Challenges

Limited Awareness and Misdiagnosis

One of the most significant obstacles in the impingement syndrome market is the limited awareness of the condition, both among the general public and healthcare professionals. Many individuals experiencing shoulder or hip pain may not immediately recognize the symptoms as indicative of impingement syndrome, often attributing the discomfort to general wear and tear, muscle strain, or other non-specific causes. This lack of awareness can lead to delayed diagnoses and subsequent delays in appropriate treatment, which can worsen the condition and increase the complexity of treatment. Additionally, healthcare providers may overlook the symptoms as they may present similarly to other musculoskeletal disorders, such as tendonitis or rotator cuff injuries, further complicating the diagnosis. The absence of early intervention can lead to chronic pain, impaired mobility, and a greater risk of developing secondary complications, ultimately contributing to higher healthcare costs due to prolonged treatment and rehabilitation needs. Increased education and awareness, particularly among general practitioners and physical therapists, are essential for timely identification and intervention.

Key Market Trends

Technological Advancements

Technological advancements have revolutionized healthcare across the globe, and the field of orthopedics is no exception. One area where these advancements are making a significant impact is in the treatment and management of Impingement Syndrome. This condition, characterized by pain and restricted movement in the shoulder, has traditionally been treated through conservative measures like physical therapy and anti-inflammatory medications. However, the integration of innovative technologies into the medical field is now opening up new avenues for diagnosis and treatment, transforming the global Impingement Syndrome market. In January 2023, Orthofix Medical Inc. and SeaSpine Holdings Corporation have successfully completed their previously announced merger of equals, following approval from the stockholders of both companies during their respective special meetings. A remarkable 99% of SeaSpine common shares and 98% of Orthofix common shares were voted in favor of the merger.

The advent of high-resolution imaging technologies like magnetic resonance imaging (MRI) and ultrasound has greatly improved the accuracy of diagnosing Impingement Syndrome. These tools allow healthcare professionals to visualize the shoulder joint and surrounding tissues in detail, enabling more precise diagnosis and treatment planning. Three-dimensional modeling techniques have emerged as powerful tools in the diagnosis of Impingement Syndrome. By creating detailed 3D models of the shoulder joint, doctors can better understand the structural issues contributing to impingement and plan interventions accordingly.

Key Market Players

• Bioventus LLC
• Orthofix Medical Inc.
• Breg, Inc.
• ConMed Corporation
• Ossur hf.
• Arthrex, Inc.
• Globus Medical, Inc.
• NuVasive, Inc.
• Stryker Corporation
• Medtronic plc

Report Scope:

In this report, the Global Impingement Syndrome Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Impingement Syndrome Market, By Type of Musculoskeletal Disorder:

• Osteoarthritis
• Rheumatoid Arthritis
• Osteoporosis
• Back and Neck Pain
• Shoulder Impingement Syndrome
• Knee Pain and Disorders

Impingement Syndrome Market, By Diagnosis and Imaging Techniques:

• X-ray
• Magnetic Resonance Imaging (MRI)
• Computed Tomography (CT) Scan
• Ultrasound
• Arthroscopy
• Others

Impingement Syndrome Market, By Treatment Modalities:

• Medications
• Surgical Interventions

Impingement Syndrome Market, By End User:

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Impingement Syndrome Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Impingement Syndrome Market.

Available Customizations:

Global Impingement Syndrome market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validations
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Impingement Syndrome Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type of Musculoskeletal Disorder (Osteoarthritis, Rheumatoid Arthritis, Osteoporosis, Back and Neck Pain, Shoulder Impingement Syndrome, Knee Pain and Disorders, Hip Pain and Disorders, Trauma and Fracture, Sports Injuries, Others)
  • 5.2.2. By Diagnosis and Imaging Techniques (X-ray, Magnetic Resonance Imaging (MRI), Computed Tomography (CT) Scan, Ultrasound, Arthroscopy, Others)
  • 5.2.3. By Treatment Modalities (Medications and Surgical Interventions)
  • 5.2.4. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Impingement Syndrome Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type of Musculoskeletal Disorder
  • 6.2.2. By Diagnosis and Imaging Techniques
  • 6.2.3. By Treatment Modalities
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Impingement Syndrome Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type of Musculoskeletal Disorder
      • 6.3.1.2.2. By Diagnosis and Imaging Techniques
      • 6.3.1.2.3. By Treatment Modalities
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Impingement Syndrome Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type of Musculoskeletal Disorder
      • 6.3.2.2.2. By Diagnosis and Imaging Techniques
      • 6.3.2.2.3. By Treatment Modalities
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Impingement Syndrome Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type of Musculoskeletal Disorder
      • 6.3.3.2.2. By Diagnosis and Imaging Techniques
      • 6.3.3.2.3. By Treatment Modalities
      • 6.3.3.2.4. By End User

7. Europe Impingement Syndrome Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type of Musculoskeletal Disorder
  • 7.2.2. By Diagnosis and Imaging Techniques
  • 7.2.3. By Treatment Modalities
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Impingement Syndrome Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type of Musculoskeletal Disorder
      • 7.3.1.2.2. By Diagnosis and Imaging Techniques
      • 7.3.1.2.3. By Treatment Modalities
      • 7.3.1.2.4. By End User
  • 7.3.2. United Kingdom Impingement Syndrome Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type of Musculoskeletal Disorder
      • 7.3.2.2.2. By Diagnosis and Imaging Techniques
      • 7.3.2.2.3. By Treatment Modalities
      • 7.3.2.2.4. By End User
  • 7.3.3. Italy Impingement Syndrome Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type of Musculoskeletal Disorder
      • 7.3.3.2.2. By Diagnosis and Imaging Techniques
      • 7.3.3.2.3. By Treatment Modalities
      • 7.3.3.2.4. By End User
  • 7.3.4. France Impingement Syndrome Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type of Musculoskeletal Disorder
      • 7.3.4.2.2. By Diagnosis and Imaging Techniques
      • 7.3.4.2.3. By Treatment Modalities
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Impingement Syndrome Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type of Musculoskeletal Disorder
      • 7.3.5.2.2. By Diagnosis and Imaging Techniques
      • 7.3.5.2.3. By Treatment Modalities
      • 7.3.5.2.4. By End User

8. Asia-Pacific Impingement Syndrome Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type of Musculoskeletal Disorder
  • 8.2.2. By Diagnosis and Imaging Techniques
  • 8.2.3. By Treatment Modalities
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Impingement Syndrome Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type of Musculoskeletal Disorder
      • 8.3.1.2.2. By Diagnosis and Imaging Techniques
      • 8.3.1.2.3. By Treatment Modalities
      • 8.3.1.2.4. By End User
  • 8.3.2. India Impingement Syndrome Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type of Musculoskeletal Disorder
      • 8.3.2.2.2. By Diagnosis and Imaging Techniques
      • 8.3.2.2.3. By Treatment Modalities
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Impingement Syndrome Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type of Musculoskeletal Disorder
      • 8.3.3.2.2. By Diagnosis and Imaging Techniques
      • 8.3.3.2.3. By Treatment Modalities
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Impingement Syndrome Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type of Musculoskeletal Disorder
      • 8.3.4.2.2. By Diagnosis and Imaging Techniques
      • 8.3.4.2.3. By Treatment Modalities
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Impingement Syndrome Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type of Musculoskeletal Disorder
      • 8.3.5.2.2. By Diagnosis and Imaging Techniques
      • 8.3.5.2.3. By Treatment Modalities
      • 8.3.5.2.4. By End User

9. South America Impingement Syndrome Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type of Musculoskeletal Disorder
  • 9.2.2. By Diagnosis and Imaging Techniques
  • 9.2.3. By Treatment Modalities
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Impingement Syndrome Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type of Musculoskeletal Disorder
      • 9.3.1.2.2. By Diagnosis and Imaging Techniques
      • 9.3.1.2.3. By Treatment Modalities
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Impingement Syndrome Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type of Musculoskeletal Disorder
      • 9.3.2.2.2. By Diagnosis and Imaging Techniques
      • 9.3.2.2.3. By Treatment Modalities
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Impingement Syndrome Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type of Musculoskeletal Disorder
      • 9.3.3.2.2. By Diagnosis and Imaging Techniques
      • 9.3.3.2.3. By Treatment Modalities
      • 9.3.3.2.4. By End User

10. Middle East and Africa Impingement Syndrome Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type of Musculoskeletal Disorder
  • 10.2.2. By Diagnosis and Imaging Techniques
  • 10.2.3. By Treatment Modalities
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Impingement Syndrome Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type of Musculoskeletal Disorder
      • 10.3.1.2.2. By Diagnosis and Imaging Techniques
      • 10.3.1.2.3. By Treatment Modalities
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Impingement Syndrome Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type of Musculoskeletal Disorder
      • 10.3.2.2.2. By Diagnosis and Imaging Techniques
      • 10.3.2.2.3. By Treatment Modalities
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Impingement Syndrome Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type of Musculoskeletal Disorder
      • 10.3.3.2.2. By Diagnosis and Imaging Techniques
      • 10.3.3.2.3. By Treatment Modalities
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Bioventus LLC
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Orthofix Medical Inc.
• 14.3. Breg, Inc.
• 14.4. ConMed Corporation
• 14.5. Ossur hf.
• 14.6. Arthrex, Inc.
• 14.7. Globus Medical, Inc.
• 14.8. NuVasive, Inc.
• 14.9. Stryker Corporation
• 14.10. Medtronic plc

15. Strategic Recommendations